Morning Market Gainers

shares climbed 53.60 percent to $49.53 after

announced its plans to buy Magnetek for $50 per share.

shares jumped 39.60 percent to $4.90 after the company reported the FDA approval of the second Phase 2 protocol for MN-001 in NASH which targets NASH patients with hypertriglyceridemia.

shares rose 35.83 percent to $4.36 after Xiamen Insight Investment Co agreed to acquire Xueda Education Group for $5.50 per ADS.

surged 9.33 percent to $67.61. Teva announced its plans to buy

generic drugs unit for $40.5 billion in a cash and stock deal. Teva also reported that it has dropped its $40 billion cash and stock bid for

.

shares gained 7.44 percent to $331.14 after

announced its plans to buy Allergan's generic drugs unit for $40.5 billion in a cash and stock deal.

shares surged 3.22 percent to $192.51. Perrigo is expected to release Q2 results on August 5, 2015.

rose 2 percent to $35.15. Dougherty & Company upgraded Stratasys to Buy